Funding: The study was supported by funding from the National Institutes of Health, Loglio Collective, Stanley D. Lewis and Virginia S. Lewis Endowed Chair in Brain Tumor Research, Robert Magnin Newman Endowed Chair in Neuro-Oncology, and donations from families and friends of John Berardi, Helen Glaser, Elvera Olsen, Raymond E. Cooper and William Martinusen at UCSF.
Disclosures: Six authors reported that they had received funding from the following organizations: National Cancer Institute, Clinical and Translational Science Center and Case Cancer Center, Loglio Collective, Brain Tumor SPORE, Agios Pharmaceuticals, Inc., Bristol-Myers Squibb, AbbVie, Inc., Genentech/Roche, Merck & Co. and Novartis International AG.
Ad Statistics
Times Displayed: 175068
Times Visited: 3187 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
About UCSF:
The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF's primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area.
Back to HCB News
